7N7D
Solution structure of the MYC promoter G-quadruplex in complex with berberine: conformer A
Summary for 7N7D
Entry DOI | 10.2210/pdb7n7d/pdb |
NMR Information | BMRB: 30923 |
Descriptor | Myc2345, BERBERINE (2 entities in total) |
Functional Keywords | g-quadruplex dna, drug-dna complex, berberine, cancer, dna |
Biological source | Homo sapiens |
Total number of polymer chains | 1 |
Total formula weight | 7706.24 |
Authors | Dickerhoff, J.,Yang, D. (deposition date: 2021-06-10, release date: 2021-11-03, Last modification date: 2024-05-15) |
Primary citation | Dickerhoff, J.,Brundridge, N.,McLuckey, S.A.,Yang, D. Berberine Molecular Recognition of the Parallel MYC G-Quadruplex in Solution. J.Med.Chem., 64:16205-16212, 2021 Cited by PubMed Abstract: The medicinal natural product berberine is one of the most actively studied and pursued G-quadruplex (G4)-ligands. The major G-quadruplex formed in the promoter region of the MYC oncogene (MycG4) is an attractive drug target and a prominent example and model structure for parallel G-quadruplexes. G4-targeted berberine derivatives have been actively developed; however, the analogue design was based on a previous crystal structure in which berberine binds as a dimer to a parallel G-quadruplex. Herein, we show that in solution, the binding mode and stoichiometry of berberine are substantially different from the crystal structure: berberine binds as a monomer to MycG4 using a base-recruitment mechanism with a reversed orientation in that the positively charged convex side is actually positioned above the tetrad center. Our structure provides a physiologically relevant basis for the future structure-based rational design of G4-targeted berberine derivatives, and this study demonstrates that it is crucial to validate the ligand-DNA interactions. PubMed: 34677968DOI: 10.1021/acs.jmedchem.1c01508 PDB entries with the same primary citation |
Experimental method | SOLUTION NMR |
Structure validation
Download full validation report